China-based MGI Tech Singapore Pte. Ltd. and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Science have announced collaboration on a multi-omics laboratory, according to a PR Newswire report.

As part of MGI's global DCS Lab initiative, this joint effort integrates MGI's genomic sequencing and multi-omics technologies into pharmaceutical education, research and drug discovery. The facility marks a milestone in MGI's mission to empower researchers with high-precision analytical tools bridging fundamental biology to frontier life science investigations.

MGI will support NUS PPS in establishing a high-performance multi-omics environment. The laboratory features an integrated instrument portfolio designed to provide deep insights across DNA genomics, cell omics and spatial omics. This technology suite offers streamlined workflow, enabling NUS PPS researchers to execute complex assignments across various omics layers for applications in precision medicine, drug discovery and pharmaceutical sciences.

"We are honored to partner with NUS Pharmacy and Pharmaceutical Sciences, a world-class department pushing the boundaries of pharmaceutical science," said Dr Liu Xin, vice president of MGI. "By providing cutting-edge technology platforms—from genomics to multi-omics—we are equipping tomorrow's pharmacists and researchers with the tools to drive discovery. We expect this multi-omics laboratory to become a catalyst for breakthrough science, demonstrating that the synergy between advanced technology and academic excellence is the key to unlocking the future of precision medicine."

"We are proud to embark on this meaningful partnership that unites our shared commitment to scientific excellence and innovation," said Professor Giorgia Pastorin, head of department at NUS PPS. "Together, we look forward to advancing discoveries that shape the future of healthcare and elevate the impact of translational research."

Launched in 2023, MGI's DCS Lab Initiative represents the company's first global programme targeting international laboratories focused on frontier science. MGI has supported establishment of over 30 DCS labs worldwide.

Read the complete report on MGI Tech's NUS Pharmacy collaboration and pharmaceutical sciences innovation strategy.